In vitro studies showed that the cytotoxic activity of immunoliposomes was enhanced compared to the free drug and untargeted liposomes, indicating that the use of FZD10 protein as a novel, effective target for colorectal cancer should be explored [135]. This evidence concerns the gene FZD10 and colorectal cancer.